Keyphrases
Adjuvant Chemotherapy
100%
Lobular Breast Cancer
100%
Postmenopausal Patients
100%
Invasive Ductal
100%
Combination Therapy
75%
Lobular Cancer
75%
Ductal Cancer
75%
Confidence Interval
50%
Hazard Ratio
50%
Neoadjuvant Endocrine Therapy
50%
Hormonal Therapy
50%
Hormonal Treatment
50%
Netherlands
25%
Cancer Registry
25%
Histology
25%
Survival Rate
25%
Beneficial Effects
25%
Neoadjuvant Chemotherapy
25%
Lack of Response
25%
One-group
25%
Overall Survival Rate
25%
Invasive Lobular Breast Cancer
25%
10-year Survival
25%
INIS
patients
100%
cancer
100%
chemotherapy
100%
breasts
100%
therapy
63%
hormones
54%
comparative evaluations
18%
hazards
18%
women
9%
mortality
9%
netherlands
9%
histology
9%
Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
100%
Adjuvant Chemotherapy
100%
Hormone Therapy
66%
Combination Therapy
50%
Hazard Ratio
33%
Survival Rate
33%
Overall Survival
16%
Cancer Registry
16%
Neoadjuvant Chemotherapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Breast Cancer
100%
Chemotherapy
100%
Hormone Cancer Therapy
66%
Combination Therapy
50%
Survival Rate
33%
Overall Survival
16%
Cancer Registry
16%